Lv Zongyang, Yuan Lingmin, Atkison James H, Aldana-Masangkay Grace, Chen Yuan, Olsen Shaun K
Department of Biochemistry and Molecular Biology and Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina 29425.
Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California 91010.
J Biol Chem. 2017 Jul 21;292(29):12089-12099. doi: 10.1074/jbc.M117.787622. Epub 2017 Jun 1.
E1 enzymes for ubiquitin (Ub) and Ub-like modifiers (Ubls) harbor two catalytic activities that are required for Ub/Ubl activation: adenylation and thioester bond formation. Structural studies of the E1 for the Ubl mall biquitin-like difier (SUMO) revealed a single active site that is transformed by a conformational switch that toggles its competency for catalysis of these two distinct chemical reactions. Although the mechanisms of adenylation and thioester bond formation revealed by SUMO E1 structures are thought to be conserved in Ub E1, there is currently a lack of structural data supporting this hypothesis. Here, we present a structure of Uba1 in which the second catalytic cysteine half-domain (SCCH domain) harboring the catalytic cysteine has undergone a 106° rotation that results in a completely different network of intramolecular interactions between the SCCH and adenylation domains and translocation of the catalytic cysteine 12 Å closer to the Ub C terminus compared with previous Uba1 structures. SCCH domain alternation is accompanied by conformational changes within the Uba1 adenylation domains that effectively disassemble the adenylation active site. Importantly, the structural and biochemical data suggest that domain alternation and remodeling of the adenylation active site are interconnected and are intrinsic structural features of Uba1 and that the overall structural basis for adenylation and thioester bond formation exhibited by SUMO E1 is indeed conserved in Ub E1. Finally, the mechanistic insights provided by the novel conformational snapshot of Uba1 presented in this study may guide efforts to develop small molecule inhibitors of this critically important enzyme that is an active target for anticancer therapeutics.
泛素(Ub)和类泛素修饰因子(Ubls)的E1酶具有Ub/Ubl激活所需的两种催化活性:腺苷化和硫酯键形成。类泛素小泛素样修饰物(SUMO)的E1的结构研究揭示了一个单一的活性位点,该位点通过构象转换进行转变,从而切换其催化这两种不同化学反应的能力。尽管SUMO E1结构揭示的腺苷化和硫酯键形成机制被认为在Ub E1中是保守的,但目前缺乏支持这一假设的结构数据。在此,我们展示了Uba1的一种结构,其中含有催化半胱氨酸的第二个催化半胱氨酸结构域(SCCH结构域)发生了106°的旋转,这导致SCCH结构域与腺苷化结构域之间的分子内相互作用网络完全不同,并且催化半胱氨酸相对于先前的Uba1结构向Ub C末端移动了12 Å。SCCH结构域的变化伴随着Uba1腺苷化结构域内的构象变化,有效地拆解了腺苷化活性位点。重要的是,结构和生化数据表明,结构域变化和腺苷化活性位点的重塑是相互关联的,并且是Uba1的固有结构特征,SUMO E1所展示的腺苷化和硫酯键形成的整体结构基础在Ub E1中确实是保守的。最后,本研究中呈现的Uba1新构象快照所提供的机制见解可能会指导开发这种至关重要的酶的小分子抑制剂的努力,该酶是抗癌治疗的一个活性靶点。